COMP <GO>
INDV vs LEGN // RSI-14 & 200D SMA MOMENTUM
Indivior Pharmaceuticals Inc. (NASDAQ) VS. Legend Biotech Corporation (NASDAQ) • 15-METRIC TALLY: INDV 6
— LEGN 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LEGN
LAST: $35.37 (+0.34%) • MKT CAP: $4.17B
rsi-technicals
52.3
LAST: $21.10 (-2.45%) • MKT CAP: $4.21B
rsi-technicals
59.2
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INDV VS. LEGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INDV | LEGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 62.20% | 9.90% | +52.30 | INDV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.4x | 21.0x | -7.60 | INDV | /valuation <GO> |
| Free Cash Flow Yield | -2.24% | 2.21% | -4.45 | LEGN | /fcf-yield <GO> |
| Operating Margin | 21.10% | 13.90% | +7.20 | INDV | /operating-margins <GO> |
| Net Profit Margin | 16.90% | 10.90% | +6.00 | INDV | /net-margins <GO> |
| Revenue Growth (YoY) | 4.30% | 9.90% | -5.60 | LEGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.13 | 3.74 | -0.61 | LEGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | LEGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 52.3 | 59.2 | -6.90 | LEGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 1.04 | +0.11 | INDV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.4x | 30.5x | -12.10 | INDV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.17B | $4.21B | -$31.9M | LEGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INDV REV | LEGN REV | INDV GROSS % | LEGN GROSS % | INDV FCF | LEGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.24B | — | 80.2% | — | -$93.0M | — |
| FY 2024 | $1.19B | — | 80.6% | — | $7.0M | — |
| FY 2023 | $1.09B | — | — | — | -$349.2M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INDV // BETA 1.15
LEGN // BETA 1.04